Home/Filings/4/0000875320-09-000031
4//SEC Filing

GARRISON RICHARD C 4

Accession 0000875320-09-000031

CIK 0000875320other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 2:21 PM ET

Size

6.1 KB

Accession

0000875320-09-000031

Insider Transaction Report

Form 4
Period: 2009-05-18
GARRISON RICHARD C
SVP and Catalyst
Transactions
  • Sale

    Common Stock

    2009-05-18$28.45/sh532$15,13537,473 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,309
Footnotes (3)
  • [F1]Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1.
  • [F2]Open market sales reported on this line occurred at a weighted average price of $28.45 (range $28.12 to $28.95).
  • [F3]Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001256466

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 2:21 PM ET
Size
6.1 KB